Talk:Ofranergene obadenovec
Appearance
This article is rated Start-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | ||||||||||||||||||||||||
|
Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Ofranergene obadenovec.
|
Developer
[edit]This source states clearly that the drug is being developed by "Dana-Farber Cancer Institute; Massachusetts General Hospital; VBL Therapeutics". Why is only the last mentioned in the article? You should mention all or none, I think. Justlettersandnumbers (talk) 21:42, 23 February 2017 (UTC)
- The drug itself was developed by VBL. Dana-Farber (which is associated with Mass Gen) is being used to host clinical trials and further testing of the drug. Natureium (talk) 15:26, 24 February 2017 (UTC)
- But that isn't what the source says, is it? Justlettersandnumbers (talk) 15:44, 24 February 2017 (UTC)
- From the first sentence: "VBL Therapeutics (also known as Vascular Biogenics) is developing ofranergene obadenovec, an intravenously administered dual-action, anti-angiogenic and vascular disrupting agent (VDA), for the treatment of solid tumours." and the table further down the page: "VBL Therapeutics, Owner, Israel; Dana-Farber Cancer Institute, Collaborator, USA; Massachusetts General Hospital, Collaborator, USA" Natureium (talk) 15:50, 24 February 2017 (UTC)
- yep, the drug is owned by VBL and is being developed by them at various sites. adis lists clinical trial sites. Dana Farber is one of them. Jytdog (talk) 19:56, 29 August 2017 (UTC)
- But that isn't what the source says, is it? Justlettersandnumbers (talk) 15:44, 24 February 2017 (UTC)
Categories:
- Start-Class medicine articles
- Low-importance medicine articles
- Start-Class hematology-oncology articles
- Unknown-importance hematology-oncology articles
- Hematology-oncology task force articles
- All WikiProject Medicine pages
- Start-Class pharmacology articles
- Unknown-importance pharmacology articles
- WikiProject Pharmacology articles